Clinical Trial

A Study to Evaluate the Efficacy and Safety of AD-224

Name: A Study to Evaluate the Efficacy and Safety of AD-224 — clinical trial record (NCT06291207)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy and safety of AD-224

Protocol Amendment History 3 changes

critical Trial completed 2026-08-04

notable Primary completion moved earlier: 2025-07 -> 2025-04-07 2026-08-04

minor Completion moved earlier: 2025-07 -> 2025-04-07 2026-08-04

Trial Details

NCT Number	NCT06291207
Lead Sponsor	Addpharma Inc.
Conditions	Hypertension,Essential
Enrollment	254 participants
Start Date	2024-04-15
Primary Completion	2025-04-07 (estimated)
Study Completion	2025-04-07 (estimated)
Updated on ClinicalTrials.gov	2026-08-03